Feymer(SH:688350)2025-04-28 08:50Financial Performance - The company's operating revenue for Q1 2025 was CNY 322,347,661.35, a decrease of 10.29% compared to CNY 359,316,221.44 in the same period last year[4] - Net profit attributable to shareholders was CNY 5,421,112.50, down 60.54% from CNY 13,737,901.17 year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 1,768,416.29, reflecting an 85.05% decline from CNY 11,827,437.33 in the previous year[4] - The net cash flow from operating activities was CNY 6,406,911.14, a significant drop of 83.34% compared to CNY 38,457,270.07 last year[4] - Total operating revenue for Q1 2025 was CNY 322,347,661.35, a decrease of 10.3% compared to CNY 359,316,221.44 in Q1 2024[21] - Net profit for Q1 2025 was CNY 3,650,197.14, a decline of 69.0% from CNY 11,804,500.85 in Q1 2024[22] - Earnings per share for Q1 2025 was CNY 0.04, compared to CNY 0.11 in Q1 2024[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,676,862,836.04, down 0.86% from CNY 2,700,018,947.74 at the end of the previous year[5] - Total liabilities decreased to CNY 1,199,003,404.02 in Q1 2025 from CNY 1,225,875,968.24 in Q1 2024, a reduction of 2.2%[19] - Non-current liabilities increased to CNY 763,962,967.74 in Q1 2025 from CNY 678,668,133.03 in Q1 2024, an increase of 12.6%[19] - The company’s total equity increased slightly to CNY 1,477,859,432.02 in Q1 2025 from CNY 1,474,142,979.50 in Q1 2024, reflecting stable shareholder value[19] Cash Flow - In Q1 2025, the net cash flow from operating activities was $6.41 million, a decrease of 83.4% compared to $38.46 million in Q1 2024[24] - Total cash inflow from investment activities in Q1 2025 was $598.16 million, significantly higher than $351.79 million in Q1 2024, marking an increase of 69.9%[24] - The net cash flow from investment activities in Q1 2025 was -$179.66 million, a decline from a positive $86.83 million in Q1 2024[25] - Cash inflow from financing activities in Q1 2025 was $74.32 million, compared to $31.84 million in Q1 2024, representing an increase of 133.5%[25] - The net cash flow from financing activities improved to $69.99 million in Q1 2025, contrasting with a negative $21.34 million in Q1 2024[25] - The total cash and cash equivalents at the end of Q1 2025 were $370.60 million, down from $425.50 million at the end of Q1 2024, a decrease of 12.9%[25] Research and Development - Research and development expenses totaled CNY 14,044,520.33, a decrease of 27.10% from CNY 19,264,381.61, representing 4.36% of operating revenue[5] - The company reported a significant increase in research and development expenses to CNY 14,044,520.33 in Q1 2025 from CNY 19,264,381.61 in Q1 2024, indicating a focus on innovation despite overall cost reductions[21] Shareholder Information - The company held 2,986,722 shares through Beijing Ruishi Bang Fine Chemical Technology Co., Ltd., representing 2.45% of total shares, with 81,000 shares lent out via margin trading[14] - The top ten shareholders include Jiangsu Feixiang Chemical Co., Ltd. holding 59,438,310 shares, accounting for 48.66% of total shares[12] - The company has a total of 4,300,293 shares held in its repurchase account, which are not included in the top ten shareholders list[12] - The company has not reported any significant changes in the shareholder structure due to margin trading activities[14] Operational Status - The company reported a decrease in gross margin due to reduced sales and increased financial expenses, impacting overall profitability[8] - There are no other significant reminders regarding the company's operational status during the reporting period[15]